Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umberto Vitolo

Showing results (101-110 of 212) with videos related to

Pageof 22
Sort By:
Haematologica|October 15, 2020
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA studyChristopher R Bolen, Magdalena Klanova, Marek Trneny, et al.
Annals of Hematology|August 19, 2007
Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano LinfomiLuigi Rigacci, Umberto Vitolo, Luca Nassi, et al.
Leukemia & Lymphoma|January 24, 2004
The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 casesLuigi Rigacci, Massimo Federico, Maurizio Martelli, et al.
British Journal of Haematology|March 29, 2014
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study GroupAnnarita Conconi, Markus Raderer, Silvia Franceschetti, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 3, 2016
The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma)Stephane Chauvie, Fabrizio Bergesio, Federica Fioroni, et al.
British Journal of Haematology|January 15, 2016
Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL)Francesco Zallio, Stefania Tamiazzo, Chiara Monagheddu, et al.
American Journal of Hematology|February 28, 2015
The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL)Luigi Rigacci, Benedetta Puccini, Pier Luigi Zinzani, et al.
Blood|December 3, 2003
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical studyAndrea Gallamini, Caterina Stelitano, Roberta Calvi, et al.
Leukemia Research|August 29, 2017
Post-remissional and pre-transplant role of minimal residual disease detected by WT1 in acute myeloid leukemia: A retrospective cohort studyChiara Frairia, Semra Aydin, Ernesta Audisio, et al.
Hematological Oncology|June 4, 2014
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilizationGiuseppe Rossi, Cristina Skert, Enrico Morello, et al.
Pageof 22

Showing results (101-110 of 212) with videos related to

Sort By:
Pageof 22
Haematologica|October 15, 2020
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA studyChristopher R Bolen, Magdalena Klanova, Marek Trneny, et al.
Annals of Hematology|August 19, 2007
Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano LinfomiLuigi Rigacci, Umberto Vitolo, Luca Nassi, et al.
Leukemia & Lymphoma|January 24, 2004
The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 casesLuigi Rigacci, Massimo Federico, Maurizio Martelli, et al.
British Journal of Haematology|March 29, 2014
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study GroupAnnarita Conconi, Markus Raderer, Silvia Franceschetti, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 3, 2016
The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma)Stephane Chauvie, Fabrizio Bergesio, Federica Fioroni, et al.
British Journal of Haematology|January 15, 2016
Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL)Francesco Zallio, Stefania Tamiazzo, Chiara Monagheddu, et al.
American Journal of Hematology|February 28, 2015
The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL)Luigi Rigacci, Benedetta Puccini, Pier Luigi Zinzani, et al.
Blood|December 3, 2003
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical studyAndrea Gallamini, Caterina Stelitano, Roberta Calvi, et al.
Leukemia Research|August 29, 2017
Post-remissional and pre-transplant role of minimal residual disease detected by WT1 in acute myeloid leukemia: A retrospective cohort studyChiara Frairia, Semra Aydin, Ernesta Audisio, et al.
Hematological Oncology|June 4, 2014
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilizationGiuseppe Rossi, Cristina Skert, Enrico Morello, et al.
Pageof 22